This compensation does not influence the accuracy, neutrality, or integrity of the information presented
Additionally, using expired injections could pose a safety risk , as the sterility and effectiveness of the solution can degrade
Putting the evidence side by side Here is the blunt comparison: AOD 9604: 2.6 kg weight loss in 12 weeks (best result), failed six clinical trials, development terminated Semaglutide: 15 to 17 percent body weight loss over 68 weeks, FDA approved, thousands of study participants, consistent results across multiple trials There is no way to frame this comparison that puts AOD 9604 on equal footing with semaglutide when it comes to clinical evidence
Seek immediate medical attention for severe abdominal pain, persistent vomiting, signs of dehydration, or allergic reactions